Evidence map›Paper›PMID 36678246›Full record

Observational studyNutrients2023

Prevalence of Radiological Chronic Pancreatitis and Exocrine Pancreatic Insufficiency in Patients with Decompensated Liver Disease: Is Fecal Elastase Useful in This Setting?

Gemma Llibre-Nieto, Alba Lira, Mercedes Vergara, Meritxell Casas, Cristina Solé, José Ferrusquía-Acosta, Valentí Puig-Diví, Laia Grau-López, Josep Maria Barradas, Marta Solà and 2 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Gemma Llibre-NietoUnitat Hepatologia, Servei Aparell Digestiu, Hospital Universitari Parc Taulí, Institut d'Investigació i Innovació Parc Taulí (I3PT), 08208 Sabadell, Spain.
Alba LiraUnitat Hepatologia, Servei Aparell Digestiu, Hospital Universitari Parc Taulí, Institut d'Investigació i Innovació Parc Taulí (I3PT), 08208 Sabadell, Spain.
Mercedes VergaraUnitat Hepatologia, Servei Aparell Digestiu, Hospital Universitari Parc Taulí, Institut d'Investigació i Innovació Parc Taulí (I3PT), 08208 Sabadell, Spain.ORCID 0000-0002-6971-8657
Meritxell CasasUnitat Hepatologia, Servei Aparell Digestiu, Hospital Universitari Parc Taulí, Institut d'Investigació i Innovació Parc Taulí (I3PT), 08208 Sabadell, Spain.
Cristina SoléUnitat Hepatologia, Servei Aparell Digestiu, Hospital Universitari Parc Taulí, Institut d'Investigació i Innovació Parc Taulí (I3PT), 08208 Sabadell, Spain.ORCID 0000-0002-6104-8345
José Ferrusquía-AcostaUnitat Hepatologia, Servei Aparell Digestiu, Hospital Universitari Parc Taulí, Institut d'Investigació i Innovació Parc Taulí (I3PT), 08208 Sabadell, Spain.
Valentí Puig-DivíUnitat Gastroenterología, Servei Aparell Digestiu, Hospital Universitari Parc Taulí, Institut d'Investigacio i Innovació Parc Taulí (I3PT), 08208 Sabadell, Spain.
Laia Grau-LópezEstadística, Servei de Neurologia, Hospital Germans Trias i Pujol, 08916 Badalona, Spain.
Josep Maria BarradasServei d'Infermeria, Unitat Hepatologia, Servei d'Aparell Digestiu, Hospital Universitari Parc Taulí, Institut d'Investigacio i Innovació Parc Taulí (I3PT), 08208 Sabadell, Spain.
Marta SolàServei de Diagnòstic per la Imatge, Hospital Universitari Parc Taulí, Institut d'Investigacio i Innovació Parc Taulí (I3PT), 08208 Sabadell, Spain.
Mireia MiquelUnitat Hepatologia, Servei Aparell Digestiu, Hospital Universitari Parc Taulí, Institut d'Investigació i Innovació Parc Taulí (I3PT), 08208 Sabadell, Spain.ORCID 0000-0003-4566-4962
Jordi Sánchez-DelgadoUnitat Hepatologia, Servei Aparell Digestiu, Hospital Universitari Parc Taulí, Institut d'Investigació i Innovació Parc Taulí (I3PT), 08208 Sabadell, Spain.
Institute of Research and Innovation Parc Tauli · ESUniversitat Autònoma de Barcelona · ESInstituto de Salud Carlos III · ESHospital Universitari Germans Trias i Pujol · ESUniversitat de Vic - Universitat Central de Catalunya · ES

Funding

Corporació Sanitària Parc Taulí 6000€
6 · The paper itself

Abstract

Chronic alcohol consumption is a well-known etiological factor for both chronic pancreatitis (CP) and liver cirrhosis. However, there is discussion over how often these two entities are present together in the same patient. The main goal of our study is to establish the prevalence of CP and low fecal elastase (FE-1) in patients with decompensated liver disease (DLD). In addition, we aim to identify the demographic, epidemiological and clinical factors associated with EPI and CP in patients with decompensated liver cirrhosis. This was an observational single-center study including 119 consecutive patients hospitalized for acute decompensation of cirrhosis, mostly of alcoholic etiology. Patients underwent computed tomography (CT) or magnetic resonance imaging (MRI) to assess the radiological features of CP. We also performed two FE-1 tests and complete blood tests to assess the presence of exocrine pancreatic insufficiency (EPI) and nutritional status, including micronutrients. The results of our study show that 32 patients (26.9%) had low fecal elastase suggesting EPI and 11 (9.2%) had CP. Patients meeting radiological CP criteria had lower FE-1 than patients without CP. There were no statistically significant differences in micronutrient deficiencies according to the presence of CP or not. Likewise, we did not find any statistically significant differences in micronutrient deficiencies among patients with normal and low FE-1 indicative of EPI. FE-1 alone may not be suitable for assessing EPI in patients with acute DLD. Detecting co-existing pancreatic disease may be important in a subset of patients with DLD, when the FE-1 levels are significantly low, potentially suggestive of a pancreatic anomaly. Moreover, the clinical manifestations of EPI and CP are not useful in detecting CP in DLD patients. Likewise, CP cannot explain all causes of EPI in these patients.

Indexed as

Exocrine Pancreatic InsufficiencyLiver DiseasesMalnutritionPancreatitis, ChronicHumansLiver CirrhosisPancreatic ElastasePrevalencePancreatic Elastasechronic pancreatitisdecompensated cirrhosisexocrine pancreatic insufficiencymicronutrient deficiencies

Identifiers

PMID36678246
PMCPMC9861070
OpenAlexW4315699999

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.